Nombre del producto:2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine
IUPAC Name:2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine
Product Overview |
2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine (CMFTP) is a nitrogen-containing heterocyclic compound that has been gaining attention in recent years due to its potential applications in the pharmaceutical and agrochemical industries. This compound has been studied for its ability to act as a catalyst in organic synthesis and as a reagent in the synthesis of other compounds. It has also been investigated for its potential as an inhibitor of enzymes involved in diseases such as cancer, diabetes, and Alzheimer's. |
Synthesis and Application |
2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine can be synthesized using a variety of methods, including the reaction of 2-chloro-3-fluoropyridine with trifluoromethyl iodide. This reaction produces the desired compound in a high yield of up to 95%. Alternatively, 2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine can also be synthesized by the reaction of 2-chloro-3-fluoropyridine with trifluoromethyl bromide in the presence of a Lewis acid catalyst. This reaction has a lower yield of up to 70%. 2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine has been studied for its potential applications in scientific research. It has been used as a catalyst in organic synthesis, as a reagent in the synthesis of other compounds, and as an inhibitor of enzymes involved in diseases such as cancer, diabetes, and Alzheimer's. It has also been investigated for its ability to induce apoptosis in cancer cells, inhibit the growth of tumor cells, and modulate the activity of certain enzymes. |
Future Directions |
There are many potential future directions for the research of 2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine. These include further investigation into its mechanism of action, its potential applications in the pharmaceutical and agrochemical industries, and its potential as an inhibitor of enzymes involved in diseases such as cancer, diabetes, and Alzheimer's. Additionally, further research could focus on the development of new synthetic methods for the production of 2-(chloromethyl)-3-fluoro-5-(trifluoromethyl)pyridine, as well as the exploration of its potential as a therapeutic agent. |